Summary of Purpose
The purpose of this study is to determine whether the combined treatment with Uric Acid and rtPA is superior to rtPA alone in terms of clinical efficacy in acute ischemic stroke patients treated within the first 4.5 hours of symptoms onset.Read More →
The following dates are available for this trial. Trial information last updated on 9 March 2015.
|1 Jun 2011||11 Mar 2009||1 Aug 2013||1 Oct 2013||1 Mar 2015||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Allocation: Randomized
- Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
- Purpose: Treatment
- Endpoint: Efficacy Study
- Intervention: Parallel Assignment
- Angel Chamorro, MD, PhD.